These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10165826)

  • 1. An economic evaluation of the use of granulocyte colony-stimulating factor after bone marrow transplantation in children.
    Duncan N; Hewetson M; Atra A; Dick G; Pinkerton R
    Pharmacoeconomics; 1997 Feb; 11(2):169-74. PubMed ID: 10165826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children.
    Saarinen UM; Hovi L; Juvonen E; Riikonen P; Möttönen M; Mäkipernaa A
    Med Pediatr Oncol; 1996 Jun; 26(6):380-6. PubMed ID: 8614373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed commencement of granulocyte colony-stimulating factor following autologous bone marrow transplantation accelerates neutrophil recovery and is cost-effective.
    Clark RE; Shlebak AA; Creagh MD
    Leuk Lymphoma; 1994 Dec; 16(1-2):141-6. PubMed ID: 7535142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
    Goa KL; Bryson HM
    Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.
    Schriber JR; Negrin RS; Chao NJ; Long GD; Horning SJ; Blume KG
    Leukemia; 1993 Oct; 7(10):1491-5. PubMed ID: 7692189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal timing of granulocyte colony-stimulating factor (G-CSF) administration after bone marrow transplantation. A prospective randomized study.
    Torres Gómez A; Jimenez MA; Alvarez MA; Rodriguez A; Martin C; Garcia MJ; Flores R; Sanchez J; de la Torre MJ; Herrera C
    Ann Hematol; 1995 Aug; 71(2):65-70. PubMed ID: 7544628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K; Rzepecki P; Oborska S; Wasko-Grabowska A
    Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF after autologous bone marrow transplantation for malignant diseases in children. Spanish Working Party for Bone Marrow Transplantation in Children.
    Madero L; Muõnz A; Diaz de Heredia A; Martínez A; Badell I; Esquembre C; Ramírez M; Otheo E; Olive A; Sastre A
    Bone Marrow Transplant; 1995 Mar; 15(3):349-51. PubMed ID: 7541268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P
    Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR; Ji SQ; Wang HX; Yan HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S; Chen H; Wang H; Yan H; Pan S
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
    Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial.
    Klumpp TR; Mangan KF; Goldberg SL; Pearlman ES; Macdonald JS
    J Clin Oncol; 1995 Jun; 13(6):1323-7. PubMed ID: 7538555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in autologous bone marrow transplantation].
    Takahashi S; Asano S; Masaoka T; Takaku F; Niitsu Y; Shibuya A; Saito H; Sekine I; Sanpi K; Hanada R
    Rinsho Ketsueki; 1991 Mar; 32(3):221-6. PubMed ID: 1710295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
    Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
    Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.